Loading...
Please wait, while we are loading the content...
Exacerbated in fl ammatory arthritis in response to hyperactive gp 130 signalling is independent of IL-17 A
| Content Provider | Semantic Scholar |
|---|---|
| Author | Jones, Gareth W. Greenhill, Claire J. Williams, Jessica O. Nowell, Mari Ann Williams, Anwen Siân Jenkins, Brendan J. Jones, Sarah A. |
| Copyright Year | 2013 |
| Abstract | To cite: Jones GW, Greenhill CJ, Williams JO, et al. Ann Rheum Dis Published Online First: [please include Day Month Year] doi:10.1136/ annrheumdis-2013-203771 ABSTRACT Objective Interleukin (IL)-17A producing CD4 T-cells (TH-17 cells) are implicated in rheumatoid arthritis (RA). IL-6/STAT3 signalling drives TH-17 cell differentiation, and hyperactive gp130/STAT3 signalling in the gp130 mouse promotes exacerbated pathology. Conversely, STAT1-activating cytokines (eg, IL-27, IFN-γ) inhibit TH-17 commitment. Here, we evaluate the impact of STAT1 ablation on TH-17 cells during experimental arthritis and relate this to IL-17A-associated pathology. Methods Antigen-induced arthritis (AIA) was established in wild type (WT), gp130 mice displaying hyperactive gp130-mediated STAT signalling and the compound mutants gp130:Stat1 and gp130: Il17a mice. Joint pathology and associated peripheral TH-17 responses were compared. Results Augmented gp130/STAT3 signalling enhanced TH-17 commitment in vitro and exacerbated joint pathology. Ablation of STAT1 in gp130 mice (gp130: Stat1) promoted the hyperexpansion of TH-17 cells in vitro and in vivo during AIA. Despite this heightened peripheral TH-17 cell response, disease severity and the number of joint-infiltrating T-cells were comparable with that of WT mice. Thus, gp130-mediated STAT1 activity within the inflamed synovium controls T-cell trafficking and retention. To determine the contribution of IL-17A, we generated gp130:IL-17a mice. Here, loss of IL-17A had no impact on arthritis severity. Conclusions Exacerbated gp130/STAT-driven disease in AIA is associated with an increase in joint infiltrating T-cells but synovial pathology is IL-17A independent. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://ard.bmj.com/content/annrheumdis/early/2013/07/26/annrheumdis-2013-203771.full.pdf |
| Alternate Webpage(s) | http://ard.bmj.com/content/annrheumdis/72/10/1738.full.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |